No Data
Wells Fargo Initiates Relay Therapeutics(RLAY.US) With Hold Rating, Announces Target Price $4
This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Wells Fargo Initiates Relay Therapeutics at Equalweight With $4 Price Target
Is Relay Therapeutics (NASDAQ:RLAY) In A Good Position To Invest In Growth?
Barbara Weber, M.D., Elected to ITM Supervisory Board
Relay Therapeutics Weakness Brings Buying Opportunity, Says Barclays